Stockscreener 앱 받기
21.58
0.61%
0.10
전일 마감가:
$21.48
열려 있는:
$21.47
하루 거래량:
610.36K
Relative Volume:
0.37
시가총액:
$1.16B
수익:
$796.00M
순이익/손실:
$-136.49M
주가수익비율:
-10.33
EPS:
-2.09
순현금흐름:
$-64.24M
1주 성능:
+23.70%
1개월 성능:
+28.02%
6개월 성능:
-34.73%
1년 성능:
-51.68%
1일 변동 폭
$20.86
$21.80
1주일 범위
$16.34
$21.80
52주 변동 폭
$15.75
$53.69
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
명칭
Tandem Diabetes Care Inc
전화
858-366-6900
주소
12400 HIGH BLUFF DRIVE, San Diego, CA
TNDM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
21.61 | 1.16B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
132.78 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.46 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.10 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.33 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.32 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2025-03-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-03-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-10-02 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-22 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 개시 | Canaccord Genuity | Buy |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-04-29 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | 업그레이드 | Stifel | Hold → Buy |
| 2023-08-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-05-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-04-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-08-09 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 개시 | Wells Fargo | Overweight |
| 2020-07-31 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-18 | 재확인 | Raymond James | Outperform |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-06 | 개시 | Raymond James | Outperform |
| 2020-02-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 개시 | Guggenheim | Buy |
| 2019-10-04 | 업그레이드 | UBS | Neutral → Buy |
| 2019-05-17 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-13 | 개시 | SVB Leerink | Outperform |
| 2019-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2019-03-05 | 재확인 | BofA/Merrill | Neutral |
| 2019-02-27 | 재확인 | Lake Street | Buy |
| 2018-11-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 재확인 | Dougherty & Company | Buy |
| 2018-09-26 | 재확인 | Piper Jaffray | Overweight |
모두보기
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
INVESTOR ALERT: Levi & Korsinsky Reminds Tandem Diabetes Care, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2023TNDM - ACCESS Newswire
Earnings Release: Here's Why Analysts Cut Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Price Target To US$35.52 - simplywall.st
Tandem Diabetes jumps as overseas sales drive Q1 beat - MSN
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Tandem Diabetes Care, Inc.(TNDM) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates - MSN
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2025 Earnings Call Transcript - Insider Monkey
TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up - Yahoo Finance
Tandem Diabetes Care First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Tandem Diabetes Care (TNDM): Analyst Maintains "Buy" Rating and Raises Target Price | TNDM Stock News - GuruFocus
Tandem Diabetes (TNDM) Shares Surge on Robust Q1 Revenue - GuruFocus
Tandem Diabetes Care Reports Record Sales and Strategic Growth - TipRanks
Tandem Diabetes stock jumps on Q1 results (TNDM:NASDAQ) - Seeking Alpha
TNDM: Stifel Adjusts Price Target for Tandem Diabetes Care | TND - GuruFocus
Tandem Diabetes Care (TNDM) Target Price Lowered by Wells Fargo - GuruFocus
TNDM: Piper Sandler Adjusts Price Target Amid Overweight Rating - GuruFocus
TNDM: Piper Sandler Adjusts Price Target Amid Overweight Rating | TNDM Stock News - GuruFocus
TNDM: Baird Maintains Neutral Rating, Lowers Price Target | TNDM Stock News - GuruFocus
Canaccord raises Tandem Diabetes Care target to $59 - Investing.com
Tandem Diabetes Care Stock: A Deep Dive Into Analyst Perspectives (10 Ratings) - Benzinga
Tandem Diabetes (TNDM) Sees Price Target Reduced by Baird | TNDM Stock News - GuruFocus
Tandem Diabetes (TNDM) Price Target Raised by Canaccord Amid Pro - GuruFocus
Tandem Diabetes (TNDM) Target Price Revised as Analysts Remain O - GuruFocus
Tandem Diabetes (TNDM) Price Target Adjusted by Analyst | TNDM S - GuruFocus
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings: Revenue Surpas - GuruFocus
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights: Record Sales and Strategic ... - Yahoo
Tandem Diabetes Care Reports 22.3% Revenue Increase in Q1 CY2025News and Statistics - IndexBox
Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Nasdaq
Tandem Diabetes Care Announces First Quarter 2025 Financial Results - BioSpace
Earnings call transcript: Tandem Diabetes Care Q1 2025 Misses EPS, Stock Rises - Investing.com
Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars - Barchart.com
Tandem Diabetes Q1 2025 slides: dual-platform strategy targets underpenetrated market - Investing.com
Tandem Diabetes stock surges on revenue beat, strong guidance By Investing.com - Investing.com South Africa
Tandem Diabetes stock surges on revenue beat, strong guidance - Investing.com Australia
Tandem Diabetes Care Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Tandem's (TNDM) Strong Q1 Revenue Surpasses Expectations | TNDM Stock News - GuruFocus
Earnings Flash (TNDM) Tandem Diabetes Care Reports Q1 Loss $-1.97 Per Share, vs. FactSet Est of $-0.60 - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
Recall Affecting Diabetic Patients in 29 States Receives FDA’s Highest Risk Warning - The Healthy @Reader's Digest
Insights into Tandem Diabetes Care's Upcoming Earnings - Nasdaq
Tandem Diabetes (TNDM) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Automated Insulin Delivery System Market Is Booming Worldwide - openPR.com
Medtronic seeks FDA nod for insulin pump, furthering Abbott collab - Yahoo Finance
When the Price of (TNDM) Talks, People Listen - news.stocktradersdaily.com
Reasons to Hold TNDM Stock in Your Portfolio for Now - MSN
RBC Capital Adjusts Tandem Diabetes (TNDM) Price Target Before Q - GuruFocus
RBC Cuts Price Target on Tandem Diabetes Care to $45 From $55, Keeps Outperform Rating - marketscreener.com
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks - Yahoo Finance
Mizuho Initiates Coverage of Tandem Diabetes Care (LSE:0M0F) with Neutral Recommendation - Nasdaq
Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last? - Yahoo Finance
Mizuho Initiates Coverage of Tandem Diabetes Care (TNDM) with Neutral Recommendation - Nasdaq
Forecasting The Future: 9 Analyst Projections For Tandem Diabetes Care - Benzinga
Tandem Diabetes Care Inc (TNDM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
12.05%
0.02%
자본화:
|
볼륨(24시간):